Literature DB >> 31451308

Charged particle beams to cure cancer: Strengths and challenges.

Marco Durante1, Jay Flanz2.   

Abstract

Charged particle therapy is the most advanced radiotherapy method in oncology. The favorable depth-dose distribution and the biological properties of charged particles have potentially a great benefit for reducing toxicity and increasing the local control. While the number of proton centers is exponentially growing worldwide, the therapy remains controversial due to the high cost and lack of level-I evidence of superior effectiveness compared to conventional X-rays. Here we will discuss the advantages and the challenges in both physics and biology to fully exploit the potential of ion therapy in medicine. The challenges include reducing the footprint and costs of accelerators, reducing range uncertainty, exploitation of the biological advantages such as the high effectiveness against hypoxic tumors, and to select patients with biology-driven personalized approaches. International collaboration in the field is likely to bring definite answers to these ongoing problems.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Accelerators; Carbon ions; Particle therapy; Protons; Radiobiology; Range

Mesh:

Year:  2019        PMID: 31451308     DOI: 10.1053/j.seminoncol.2019.07.007

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  7 in total

1.  Fixed Beamline Optimization for Intensity Modulated Carbon-Ion Therapy.

Authors:  Pavitra Ramesh; Hengjie Liu; Wenbo Gu; Ke Sheng
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2021-06-25

2.  Radioactive Beams for Image-Guided Particle Therapy: The BARB Experiment at GSI.

Authors:  Daria Boscolo; Daria Kostyleva; Mohammad Javad Safari; Vasiliki Anagnostatou; Juha Äystö; Soumya Bagchi; Tim Binder; Georgios Dedes; Peter Dendooven; Timo Dickel; Vasyl Drozd; Bernhard Franczack; Hans Geissel; Chiara Gianoli; Christian Graeff; Tuomas Grahn; Florian Greiner; Emma Haettner; Roghieh Haghani; Muhsin N Harakeh; Felix Horst; Christine Hornung; Jan-Paul Hucka; Nasser Kalantar-Nayestanaki; Erika Kazantseva; Birgit Kindler; Ronja Knöbel; Natalia Kuzminchuk-Feuerstein; Bettina Lommel; Ivan Mukha; Chiara Nociforo; Shunki Ishikawa; Giulio Lovatti; Munetaka Nitta; Ikechi Ozoemelam; Stephane Pietri; Wolfgang R Plaß; Andrej Prochazka; Sivaji Purushothaman; Claire-Anne Reidel; Heidi Roesch; Fabio Schirru; Christoph Schuy; Olga Sokol; Timo Steinsberger; Yoshiki K Tanaka; Isao Tanihata; Peter Thirolf; Walter Tinganelli; Bernd Voss; Uli Weber; Helmut Weick; John S Winfield; Martin Winkler; Jianwei Zhao; Christoph Scheidenberger; Katia Parodi; Marco Durante
Journal:  Front Oncol       Date:  2021-08-19       Impact factor: 5.738

3.  Physics and biomedical challenges of cancer therapy with accelerated heavy ions.

Authors:  Marco Durante; Jürgen Debus; Jay S Loeffler
Journal:  Nat Rev Phys       Date:  2021-09-17

Review 4.  From Photon Beam to Accelerated Particle Beam: Antimetastasis Effect of Combining Radiotherapy With Immunotherapy.

Authors:  Liqiu Ma
Journal:  Front Public Health       Date:  2022-03-29

Review 5.  Could Protons and Carbon Ions Be the Silver Bullets Against Pancreatic Cancer?

Authors:  Camille Huart; Jia-Wei Chen; Benjamin Le Calvé; Carine Michiels; Anne-Catherine Wéra
Journal:  Int J Mol Sci       Date:  2020-07-04       Impact factor: 6.208

6.  Radioactive Beams in Particle Therapy: Past, Present, and Future.

Authors:  Marco Durante; Katia Parodi
Journal:  Front Phys       Date:  2020-08-28

Review 7.  Particle therapy in Europe.

Authors:  Cai Grau; Marco Durante; Dietmar Georg; Johannes A Langendijk; Damien C Weber
Journal:  Mol Oncol       Date:  2020-04-22       Impact factor: 7.449

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.